GobyMeds vs. Telehealth Platforms: When $99/Month Actually Wins

At $99/month for compounded semaglutide, GobyMeds undercuts every major telehealth platform. Here's what you get — and what you give up.

The $99 Question

GobyMeds offers compounded semaglutide at $99/month and tirzepatide at $133/month. Those are the lowest prices in the GLP-1 telehealth market by a significant margin. Embody's ongoing rate is $299/month. Sunlight is $179/month. Most other providers fall between $200–350/month.

The price gap is wide enough to raise an obvious question: what's the trade-off?

What GobyMeds Offers

GobyMeds operates as a direct pharmacy model rather than a traditional telehealth platform. They also offer NAD+ and Sermorelin alongside their GLP-1 products. The pricing includes medication and shipping, and new patients can use code x7X72r for an additional $25 off their first order.

The model is lean: less overhead means lower pricing. GobyMeds doesn't maintain the extensive clinical support infrastructure of larger platforms — no dedicated app, no elaborate check-in scheduling, no integrated coaching programs.

What Full-Service Telehealth Offers

Platforms like Found Health, Embody, and Oak Weight Loss charge more because they provide more: scheduled medical consultations, dedicated clinical support teams, side effect management protocols, dose titration guidance, and sometimes nutritional or fitness coaching.

For first-time GLP-1 users who need guidance through the initial titration period, the nausea management phase, and the adjustment to dramatically reduced appetite, these services have real value. The first 4–8 weeks on a GLP-1 medication are when patients most need medical support, and paying an extra $100–200/month for responsive clinical access during that period can be the difference between staying on treatment and quitting.

When $99/Month Wins

GobyMeds makes the most sense for patients who have already completed the initial titration with another provider and are stable on a maintenance dose. If you know your target dose, manage side effects independently, and just need reliable, affordable medication supply, GobyMeds delivers that at roughly half the price of most alternatives.

It also works well for patients who have an independent primary care doctor who can provide the clinical oversight that GobyMeds doesn't include. The medication is the same active ingredient — the difference is entirely in the wraparound services.

When It Doesn't

GobyMeds is a poor choice for first-time GLP-1 users with no prior experience, patients with complex medical histories that require close monitoring, anyone who needs structured coaching for diet, exercise, or behavioral changes, and patients who want integrated app-based tracking and regular check-ins.

The annual savings versus a mid-tier provider are roughly $1,200–2,400. That's significant. But the value of medical support during a medication that fundamentally changes your relationship with food shouldn't be underestimated.

Our Verdict

GobyMeds is the best-value GLP-1 option for experienced patients who need medication, not a program. For everyone else, the extra cost of a full-service telehealth platform is worth it — especially during the first 3–6 months of treatment.